Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 139   

Articles published

GSK 1,363.50 +18.00 (1.34%)
price chart
GlaxoSmithKline plc And Smith & Nephew plc: Healthy Stock Stars For Your ...
Despite the sterling work achieved by its R&D department over the past year, drugs giant GlaxoSmithKline (LSE: GSK) is still struggling to overcome insipid investor appetite. Shares in the firm have tracked 15% lower from last April's peaks of around ...
Why GlaxoSmithKline plc, Aviva plc & Trifast plc Are Beaming Bargains!
General insurance giant Aviva (LSE: AV) hasn't been immune to the weak risk appetite washing across financial markets, and the business has seen its shares fall 13% since the turn of the year.
GlaxoSmithKline plc: Next Stop 1600P
After nearly a year of giving GlaxoSmithKline (LSE: GSK) a wide berth, the market finally seems to be waking up to the company's potential.
Astrazeneca Plc And GlaxoSmithKline Plc: Double Or Quits?
Astrazeneca (LSE: AZN) shares have fared much better than Glaxosmithkline's (LSE: GSK) over the last 24 months, mostly due to the after-effects of Pfizer's pursuit in 2014, although neither company's performance really merits celebrating.
Should You Buy GlaxoSmithKline plc, AstraZeneca plc & Hargreaves Lansdown plc ...
I don't know about you, but I for one am glad to see the back of January. Despite my personal portfolio's small-cap growth-oriented construction, I've been along for the ride on the turbulent market roller coaster.
Neil Woodford Pumps Cash Into GlaxoSmithKline plc, Purplebricks Group PLC ...
The performance of FTSE 100 giant GlaxoSmithKline has been “frustratingly disappointing” for some years, but Woodford maintains that the market is under-appreciating the group's HIV and consumer healthcare businesses, and that the sum of the parts is ...
Are Dividends Built To Last At GlaxoSmithKline plc And Diageo plc?
Some dividends have staying power. Companies delivering enduring dividends tend to back such often-rising payouts with robust business and financial achievement.
Are GlaxoSmithKline plc & AstraZeneca plc Safe From The Market Rout?
The market turbulence so far in 2016 has many investors rattled, and time will tell if this is the beginning of a deeper downturn.
Beginners' Porfolio: Falls From GlaxoSmithKline plc, Persimmon plc & BP plc ...
This article is the latest in a series that aims to help novice investors with the stock market. To enjoy past articles in the series, please visit our full archive.
GlaxoSmithKline plc 13.8% Potential Upside Indicated by Barclays Capital
GlaxoSmithKline plc with EPIC/TICKER LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'OVERWEIGHT' this morning by analysts at Barclays Capital.
Bonness Enterprises Inc. Increases Position in GlaxoSmithKline plc (GSK)  EMQ
GlaxoSmithKline plc (GSK) Stake Boosted by Farmers Trust Co.  Financial Market News